Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 1690       

   Table of Contents      
REVIEW ARTICLE
Year : 2014  |  Volume : 140  |  Issue : 7  |  Page : 130-136

Delineating the prime mover action of progesterone for endometrial receptivity in primates


1 Department of Physiology, All India Institute of Medical Sciences, New Delhi, India
2 Department of Physiology, North DMC Medical College, Hindu Rao Hospital, Delhi, India

Date of Submission22-Jan-2013
Date of Web Publication10-Feb-2015

Correspondence Address:
D Ghosh
Department of Physiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 25673534

Rights and PermissionsRights and Permissions
   Abstract 

Progesterone is essential for endometrial receptivity in primates. It is now evident that embryo-derived signal influences implantation stage endometrium under progesterone dominance, and collectively results in endometrial receptivity to implanting blastocyst. Previously, a few studies were performed using global gene profiling based on microarray technology to identify changes in gene expression between early luteal phase and mid luteal phase endometrium, however, the issue of combinatorial regulation by progesterone-dependent regulation and by embryo-derived signal on transcripts profiles during endometrial differentiation toward receptivity for blastocyst implantation in primates has not been addressed. t0 he present review summarizes a few issues, specifically that of transforming growth factor β-tumour necrosis factor α (TGFβ-TNFα) pathways and signal transducer and activator of transcription (STAT) signalling system related to luteal phase progesterone action on endometrial receptivity in terms of its transcriptomic expression using a potent antiprogestin (mifepristone) in conception cycles of the rhesus monkey as a non-human primate model.

Keywords: Endometrium - mifepristone - receptivity - Rhesus monkey - transcriptomics


How to cite this article:
Ghosh D, Sengupta J. Delineating the prime mover action of progesterone for endometrial receptivity in primates. Indian J Med Res 2014;140, Suppl S1:130-6

How to cite this URL:
Ghosh D, Sengupta J. Delineating the prime mover action of progesterone for endometrial receptivity in primates. Indian J Med Res [serial online] 2014 [cited 2020 Aug 11];140, Suppl S1:130-6. Available from: http://www.ijmr.org.in/text.asp?2014/140/7/130/151124

Introduction

Progesterone is essential for endometrial receptivity and pregnancy maintenance in the human and non-human primates [1],[2],[3],[4],[5] . As shown in [Table 1], there are a few reports on the molecular characteristics of the 'window' of implantation in which high density cDNA microarray screening was performed for global gene profiling to essentially identify changes in gene expression between early luteal (pre-receptive) and mid luteal (receptive) phases in primate and human endometrium to elucidate steroidal regulation of endometrial physiology towards receptivity [6],[7],[8],[9],[10],[11],[12],[13],[14] . There are two studies describing the differential display of genomic expression in human endometrium in response to high affinity progesterone antagonist (mifepristone) during the period of progesterone dominance in vitro and in vivo[10],[14] . However, it is now clearly evident that a dialogue between embryo and endometrium under progesterone dominance results in complex interaction of genomic expressions that collectively manifests endometrial receptivity to an implanting blastocyst [15],[16],[17] . The potential effect of human chorionic gondotropin (hCG), a putative preimplantation stage embryo-derived signal on transcript profiles in implantation stage baboon endometrium has been demonstrated [13] . All of the above-mentioned studies, except two [10],[13] adopted an inductive approach based on genome wide expression arrays. We, on the contrary, delineated the transcripts profile during endometrial differentiation for 'receptivity' under the dual control of steroidal regulation and embryo-derived signal using a deductive approach [18] . To this effect, we have compared transcript profiles for known 409 genes between 'receptive', and mifepristone-induced desynchronized 'non-receptive' stage monkey endometrial samples from mated, potential conception cycles, using cDNA arrays containing sequence-verified clones known to be important in endometrial function [18] . In the present review, we discuss a few issues related to luteal phase progesterone action on endometrial receptivity using mifepristone as a potent antiprogestin in terms of its transcriptomic expression in fecund cycles of rhesus monkeys as a non-human primate model. The significance of transforming growth factor β-tumour necrosis factor α (TGFβ-TNFα) pathways and signal transducer and activator of transcription (STAT)signaling system under the receptivity-hostility paradigm of endometrial preparation for blastocyst implantation has been specifically addressed.
Table 1: Summary of differential expression studies in endometrial receptivity


Click here to view


Transcriptomics of receptive endometrium of conception cycle

A large number of gene products (31 out of 54) showed changes within five fold, while relatively less (23) number of genes showed more than five fold changes in both days 4 (10 out of 26 gene products) and 6 (13 out of 28 gene products) post-ovulation endometrium [18] . Further analysis revealed a total of 26 genes (20 increased and 6 decreased) on day four, and 28 genes (25 increased and 3 decreased) on day 6 after fertilization displayed significant differential expression in endometrium as a result of mifepristone treatment on day 2 after ovulation in proven fertile cycles [18] . The relative abundance of transcripts of nine gene products (Jun B, KDR, Leptin receptor, matrix metalloprotease 9 (MMP 9), ribosomal protein s7 (Rsp7), ribosomal protein s9 (Rsp9), STAT3, Tastin, TGF beta1) was higher in endometrial samples on both days 4 and 6 after ovulation following mifepristone treatment as compared to control samples and these showed progressive increase between days 4 and 6 after ovulation in mifepristone treated group. A set of another twelve gene products showed changes following mifepristone treatment only in day 4 samples; ten of these (α1-anti-trypsin, Bystin, Follistatin-like1, 3β-HSD, Integrin-α, Keratan sulphotransferase1, matrix metalloprotease 3 (MMP3), STAT-PIASγ, Tissue factor/Thromplastin and Wnt inhibitor factor were increased and two of these [erythroblastic leukemia viral oncogene B (ErB3) and Prolactin receptor] showed decreased expression. Similarly, a different set of fourteen gene products showed changes only in day 6 samples, twelve of these (CD44, cyclooxygenase 1 (COX1), DLX4, E74-like factor 1 (ELF1), interlukin 6 (IL6), JAK1, JUN, MIF, MMP10, PGFR, Thioredoxin, TNFα,) were increased and two (17, 20-desmolase, MUC1) were decreased following mifepristone treatment [18] .

New leads in transcriptomics of receptive endometrium

[Table 2] shows the common gene products appeared to be regulated by progesterone in previous reports including our study [6],[7],[8],[9],[10],[11],[12],[13],[14],[18] . [Table 2] also shows a new group of 28 gene products that were affected in implantation stage endometrium following early luteal phase administration of anti-progestin mifepristone [18] and those were not reported to be affected by progesterone in earlier array-based studies using the model of comparative study between pre-receptive and receptive stage endometrium [6],[7],[8],[9],[10],[11],[12],[13],[14] . We have validated our cDNA array based data for nine gene products using TaqMan validation; of the nine gene products, seven (CD 44, CSF-1, DLX4, Enigma, KDR, Leptin receptor, and MIF) appeared to be novel candidates, while two (MUC1 and Uteroglobin) have been reported earlier [11],[12] . While previous reports indicated that wnt-associated pathways were involved in progesterone action on endometrial differentiation [12] , changes in transcripts profiles of homeobox genes like distal less homeobox 4 (DLX4) and enigma, as well as, of transcription and translation related gene products like JunB, c-Jun, Elf1, and ribosomal proteins in implantation stage endometrium following mifepristone treatment [18] have not been reported earlier. It is assumed that endometrial receptivity in the primate is associated with categorical reprogramming in endometrial transcriptomics as observed in human endometrial fibroblasts in vitro[19] , human placental villous cytotrophoblasts in vitro[20] , and mouse decidual cells [21] . Thus, the elucidation of the time course pattern of endometrial receptivity associated transcriptomic networks will be beneficial to clinical sciences for improvising strategies to assist the establishment of pregnancy.
Table 2: Functional clustering of progesterone regulated genes in implantation stage endometrium


Click here to view


Functional correlates

General: The results of our study in the rhesus monkey [18] have substantiated earlier reports indicating that endometrial cyclooxygenase, prostaglandin receptor, matrix metalloproteinases, tissue necrosis factor, prolactin receptor and mucin are regulated in mid-luteal phase endometrium by progesterone [22],[23],[24],[25],[26],[27],[28],[29],[30],[31],[32],[33] . On the other hand, it is notable that relative abundance of transcripts for colony stimulating factor 1 (CSF1), interleukin 6 (IL-6), leptin receptor, and kinase insert domain receptor (KDR) were actually up-regulated in response to mifepristone treatment, contrary to the expected changes based on earlier reports [34],[35],[36],[37],[38],[39],[40] . Collectively, the Enrichment Analysis by Process Maps and Process Networks using Metacore platform (GeneGo, St. Joseph, MI, USA) revealed that the group of 40 genes showing differential expression in endometrium regulated by progesterone action computed upon cell cycle, differentiation and development, immune response and inflammation. Of the all the 40 genes that showed differential expression on inhibition of progesterone action in implantation stage endometrium, two gene products, namely TGFβ1 and STAT3, appear intriguing for disparate reasons as discussed below.

TGFβ: Transforming growth factor beta (TGFβ) has reportedly been observed in a good number of genome-wide expression array studies [6],[7],[8],[ [11],[12] to be involved in the process of luteal phase endometrial differentiation under progesterone dominance. TGFβ denotes a family of structurally related, dimeric protein that controls proliferation, apoptosis, cellular differentiation, angiogenesis, tissue remodelling and repair, immune responses and other functions depending on cell types, physiological states and its concentration and availability of its receptors [41],[42] . Our observation of increased TGFβ1 expression along with higher expression MMPs and TNF in mifepristone treated endometrium corroborates well with the earlier reports that (i) progesterone mediates a balance of MMPs and TNF in endometrium involving paracrine action of TGFβ[43],[44],[45] and thus it plays an important role in the process of endometrial receptivity and blastocyst implantation [46],[47] , and (ii) a very high level of TGFβ may suppress progestational maturation of endometrium [48],[49],[50] . Furthermore, we have observed that the protein expression for these mediators was higher in anti-progestin (mifepristone) treated monkey endometrium as compared to control endometrium. Thus, it appears that higher expression of TNFα and TGFβ may mediate endometrial hostility in mifepristone treated fecund cycle through a putative model function as shown in the [Figure 1].
Figure 1: A putative model based on enriched pathways analysis of transcriptomic profiles highlighting the basic seed genes operative in the progesterone-dominant implantation stage endometrium regulating endometrial receptivity (development) and hostility (death cycle). ErbB, erythroblastic leukemia viral oncogene B; Follistat, follistatin; IL6, interleukin 6; NF-kB, nuclear factor kappa-light chain enhancer of activated B cells; Smads, homologs of both the Drosophilla protein, MAD and the C. elegans protein SMA; stat, signal transducer and activator of transcription; TGFβ, transforming growth factor beta; TNFá, tumour necrosis factor alpha; VEFG, vascular endothelial growth factor.

Click here to view


STAT3 signaling: STAT3 activation in endometrium was reportedly associated with endometrial receptivity to implantation in rodents [51],[52],[53] . Furthermore, Janus Kinase 1 (JAK1) at the transcript level in human luteal phase endometrial explant cultures following mifepristone administration was reduced and immunopositve protein levels of JAK1 was higher in stroma and luminal epithelium of luteal phase endometrium as compared to other stages of menstrual cycle [10] . Thus, the observed relative higher abundance of transcripts for JAK1 and STAT3 in anti-progestin (mifepristone) treated endometrium in our study [18] appears counter-intuitive. To further examine this issue, we investigated immunohistochemically the protein products expression of activated STAT3 in endometrial samples collected on days 4 and 6 after fertilization with and without mifepristone treatment. The immunopositive signals for JAK1 and phosphorylated STAT 3 (pSTAT3) were consistently and markedly higher in epithelial compartment and were depressed in stromal and vascular compartments on days 4 and 6 after ovulation, while mifepristone treatment resulted in higher pSTAT3 in the vascular compartment [18] . Although the mechanism and function of increased expression of pSTAT3 in vascular compartment following mifepristone treatment are unclear, it is likely that inflammatory changes are triggered in luteal phase endometrium by mifepristone induced vasocentric JAK1-STAT3 pathway [54],[55] , thereby rendering endometrial hostility to blastocyst implantation. This observation corroborated well with earlier observation that early luteal phase administration of mifepristone resulted in significant changes in mid-lueal phase endometrial vascular physiology associated with phenotypic hostility of endometrium towards blastocyst implantation [56] .

In conclusion, we propose that TGFβ-TNFα pathways and STAT signaling system are important effectors in mediating the combinatorial regulation of luteal phase progesterone action on endometrial receptivity in fecund cycle.

 
   References Top

1.
Ghosh D, De P, Sengupta J. Luteal phase ovarian oestrogen is not essential for implantation and maintenance of pregnancy from surrogate embryo transfer in the rhesus monkey. Hum Reprod 1994; 9 : 629-7.  Back to cited text no. 1
    
2.
Ghosh D, Sengupta J. Endometrial receptivity for implantation. A relook into the issue of peri-implantation oestrogen. Hum Reprod 1995; 10 : 1-2.  Back to cited text no. 2
    
3.
Zegers-Hochschild F, Altieri E. Luteal phase estrogen is not required for establishment of pregnancy in the human. J Assist Reprod Genet 1995; 12 : 224-8.  Back to cited text no. 3
[PUBMED]    
4.
Paulson RJ. Hormonal induction of endometrial receptivity. Fertil Steril 2011; 96 : 530-5.  Back to cited text no. 4
    
5.
Wang N, Geng L, Zhang S, He B, Wang J. Expression of PRB, FKBP52 and HB-EGF relating with ultrasonic evaluation of endometrial receptivity. PLo s0 o0 ne 2012; 7 : e34010  Back to cited text no. 5
    
6.
Kao LC, Tulac S, Lobo S, Imani B, Yang JP, Germeyer A, et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology 2002; 143 : 2119-38.  Back to cited text no. 6
    
7.
Carson DD, Lagow E, Thathiah A, Al-Shami R, Farach-Carson MC, Vernon M, et al. Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Hum Reprod 2002; 8 : 871-9.  Back to cited text no. 7
    
8.
Borthwick JM, Charnock-Jones DS, Tom BD, Hull ML, Teirney R, Phillips SC, et al. Determination of the transcript profile of human endometrium. Mol Hum Reprod 2003; 9 : 19-33.  Back to cited text no. 8
    
9.
Riesewijk A, Martin J, van Os R, Horcajadas JA, Polman J, Pellicer A, et al. Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology. Mol Hum Reprod 2003; 9 : 253-64.  Back to cited text no. 9
    
10.
Catalano RD, Yanaihara A, Evans AL, Rocha D, Prentice A, Saidi S, et al. The effect of RU486 on the gene expression profile in an endometrial explant model. Mol Hum Reprod 2003; 9 : 465-73.  Back to cited text no. 10
    
11.
Ace CI, Okulicz WC. Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase. Reprod Biol Endocrinol 2004; 2 : 54.   Back to cited text no. 11
    
12.
Talbi S, Hamilton AE, Vo KC, Tulac S, Overgaard MT, Dosiou C, et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 2006; 147 : 1097-121.  Back to cited text no. 12
    
13.
Sherwin JR, Sharkey AM, Cameo P, Mavrogianis PM, Catalano RD, Edassery S, et al. Identification of novel genes regulated by chorionic gonadotropin in baboon endometrium during the window of implantation. Endocrinology 2007; 148 : 618-26.  Back to cited text no. 13
    
14.
Catalano RD, Critchley HO, Heikinheimo O, Baird DT, Hapangama D, Sherwin JRA, et al. Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod 2007; 13 : 641-54.  Back to cited text no. 14
    
15.
Ghosh D, Sengupta J. Endocrine and paracrine correlates of endometrial receptivity to blastocyst implantation in the human. Indian J Physiol Pharmacol 2004; 48 : 6-30.  Back to cited text no. 15
    
16.
Simon C, Dominguez F. Embryonic-endometrial interactions at implantation in humans. Gynecol Obstet Invest 2004; 57 : 28-30.  Back to cited text no. 16
    
17.
Králícková M, Síma P, Rokyta Z. Role of the leukemia-inhibitory factor gene mutations in infertile women: the embryo-endometrial cytokine cross talk during implantation--a delicate homeostatic equilibrium. Folia Microbiol (Praha) 2005; 50 : 179-86.  Back to cited text no. 17
    
18.
Ghosh D, Sharkey AM, Charnock-Jones DS, Smith SK, Sengupta J. Effect of low-dose mifepristone administration on day 2 after ovulation on transcript profiles in implantation-stage endometrium of rhesus monkeys. Reproduction 2009; 138 : 357-70.   Back to cited text no. 18
    
19.
Brar AK, Handweger S, Kessier CA, Aronow BJ. Gene induction and categorical reprogramming during in vitro human endometrial fibroblast decidualization. Physiol Genom 2001; 7 : 135-48.  Back to cited text no. 19
    
20.
Aronow BJ, Richardson BD, Handweger S. Microarray analysis of trophoblast differentiation: gene expression reprogramming in key gene function categories. Physiol Genom 2001; 6 : 105-16.  Back to cited text no. 20
    
21.
Kashiwagi A, DiGirolamo CM, Kanda Y, Niikura Y, Esmon CT, Hansen TR, et al. The post-implantation embryo differentially regulates endometrial gene expression and decidualization. Endocrinology 2007; 148 : 4173-84.  Back to cited text no. 21
    
22.
Salamonsen LA, Woolley DE. Matrix metalloproteinases in normal menstruation. Hum Reprod 1996; 11 : 124-32.  Back to cited text no. 22
    
23.
Aplin JD, Hey NA, Graham RA. Human endometrial MUC1 carries keratan sulfate: characteristic glycoforms in the luminal epithelium at receptivity. Glycobiology 1998; 8 : 269-76.  Back to cited text no. 23
    
24.
Ghosh D, Lalitkumar PGL, Sengupta J. Effect of early luteal phase administration of mifepristone (RU486) on leukemia inhibitory factor, transforming growth factor and vascular endothelial growth factor in the implantation stage endometrium of the rhesus monkey. J Endocrinol 1998; 157 : 115-25.  Back to cited text no. 24
    
25.
Nayak NR, Sengupta J, Ghosh D. Antinidatory effect of luteal phase administration of Mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window. Contraception 1998; 58 : 111-7.  Back to cited text no. 25
    
26.
Kim JJ, Wang J, Bambra C, Das SK, Dey SK, Fazleabas AT. Expression of cyclooxygenase-1 and -2 in the baboon endometrium during the menstrual cycle and pregnancy. Endocrinology 1999; 140 : 2672-8.  Back to cited text no. 26
    
27.
Marions L, Gemzell-Danielsson K. Expression of cyclo-oxygenase in human endometrium during the implantation period. Mol Hum Reprod 1999; 5 : 961-5.  Back to cited text no. 27
    
28.
Tseng L, Mazella J. Prolactin and its receptor in human endometrium. Semin Reprod Endocrinol 1999; 17 : 23-7.  Back to cited text no. 28
    
29.
Milne SA, Jabbour HN. Prostaglandin (PG) F(2alpha) receptor expression and signaling in human endometrium: role of PGF(2alpha) in epithelial cell proliferation. J Clin Endocrinol Metab 2003; 88 : 1825-32.  Back to cited text no. 29
    
30.
Stavreus-Evers A, Koraen L, Scott JE, Zhang P, Westlund P. Distribution of cycloxygenase-1 cyclooxegenase-2, and cytosolic phospholipase A2 in the luteal phase endometrium and ovary. Fertil Steril 2005; 83 : 156-62.  Back to cited text no. 30
    
31.
Lalitkumar PGL, Sengupta J, Ghosh D. Endometrial tumor necrosis factor (TNF) is a likely mediator of early luteal phase mifepristone-mediated negative effector action on the preimplantation embryo. Reproduction 2005; 129 : 323-35.  Back to cited text no. 31
    
32.
Goff AK, Jamshidi AA, Komba A. Inhibition of prostaglandin F2 alpha synthesis and oxytocin receptor by progesterone antagonist in bovine endometrial cells in vitro. Steroids 2006; 71 : 785-91.  Back to cited text no. 32
    
33.
Makino S, Zaragoza DB, Mitchell BF, Robertson S, Olson DM. Prostaglandin F2alpha and its receptor as activators of human deciduas. Semin Reprod Med 2007; 25 : 60-8.  Back to cited text no. 33
    
34.
Pollard JW. Role of colony-stimulating factor-1 in reproduction and development. Mol Reprod Develop 1997; 46 : 54-60.  Back to cited text no. 34
    
35.
Sengupta J, Dhawan L, Ghosh D. Immunohistochemical localization of leukemia inhibitory factor, interleukin 1 and 6 at the primary implantation site in the rhesus monkey. Cytokine 2003; 24 : 277-85.   Back to cited text no. 35
    
36.
Nakashima K, Narazaki M, Taga T. Leptin receptor (OB-R) oligomerizes with itself but not with its closely related cytokine signal transducer gp130. FEBS Lett 1997; 403 : 79-82.  Back to cited text no. 36
    
37.
Gonzalez RR, Simon C, Caballero-Campo P, Norman R, Chardonnens D, Devoto L, et al. Leptin and reproduction. Hum Reprod Update 2000; 6 : 290-300.  Back to cited text no. 37
    
38.
Cervero A, Horcajadas JA, MartIn J, Pellicer A, Simon C. The leptin system during human endometrial receptivity and preimplantation development. J Clin Endocrinol Metab 2004; 89 : 2442-51.  Back to cited text no. 38
    
39.
Gonzalez BY, Michel FJ, Simmen RC. A regulatory element within the uteroferrin gene 5'-flanking region binds a pregnancy-associated uterine endometrial protein. DNA Cell Biol 1994; 13 : 365-76.  Back to cited text no. 39
    
40.
Krussel JS, Casan EM, Raga F, Hirchehain J, Wen Y, Huang H-Y, et al. Expression of mRNA for vascular endothelial growth factor transmembraneous receptors FLT-1 and KDR and the soluble receptor s-flt in cycling human endometrium. Mol Hum Reprod 1999; 5 : 452-8.  Back to cited text no. 40
    
41.
Sporn MB, Roberts AB. TGF-beta: problems and prospects. Cell Regul 1990; 1 : 875-82.  Back to cited text no. 41
    
42.
Godkin JD, Doré JJ. Transforming growth factor beta and the endometrium. Rev Reprod 1998; 3 : 1-6.  Back to cited text no. 42
    
43.
Osteen KG, Igarashi TM, Bruner-Tran KL. Progesterone action in the human endometrium: induction of a unique tissue environment which limits matrix metalloproteinase (MMP) expression. Front Biosci 2003; 8 : 78-86.  Back to cited text no. 43
    
44.
Nasu K, Nishida M, Matsumoto H, Bing S, Inoue C, Kawano Y, et al. Regulation of proliferation, motility, and contractivity of cultured human endometrial stromal cells by transforming growth factor-beta isoforms. Fertil Steril 2005; 84 : 1114-23.  Back to cited text no. 44
    
45.
Braundmeier AG, Nowak RA. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer. Am J Reprod Immunol 2006; 56 : 201-14.  Back to cited text no. 45
    
46.
Ghosh D, Sengupta J. Recent developments in endocrinology and paracrinology of blastocyst implantation in the primate. Hum Reprod Update 1998; 4 : 153-68.  Back to cited text no. 46
    
47.
Sugawara K, Kizaki K, Herath CB, Hasegawa Y, Hashizume K. Transforming growth factor beta family expression at the bovine feto-maternal interface. Reprod Biol Endocrinol 2010; 8 : 1-12.  Back to cited text no. 47
    
48.
Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 1990; 63 : 515-24.  Back to cited text no. 48
    
49.
Goldberg HJ, Huszár T, Mózes MM, Rosivall L, Mucsi I. Overexpression of the type II transforming growth factor-beta receptor inhibits fibroblasts proliferation and activates extracellular signal regulated kinase and c-Jun N-terminal kinase. Cell Biol Int 2002; 26 : 165-74.  Back to cited text no. 49
    
50.
Giannouli CC, Kletsas D. TGF-beta regulates differentially the proliferation of fetal and adult human skin fibroblasts via the activation of PKA and the autocrine action of FGF-2. Cell Signal 2006; 18 : 1417-29.  Back to cited text no. 50
    
51.
Liu J, Kern JA. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation. Am J Respir Cell Mol Biol 2002; 27 : 306-13.  Back to cited text no. 51
    
52.
Catalano RD, Johnson MH, Campbell EA, Charnock-Jones DS, Smith SK, Sharkey AM. Inhibition of Stat3 activation in the endometrium prevents implantation: a nonsteroidal approach to contraception. Proc Natl Acad Sci USA 2005; 102 : 8585-90.   Back to cited text no. 52
    
53.
Nakamura H, Kimura T, Koyama S, Ogita K, Tsutsui T, Shimoya K, et al. Mouse model of human infertility: transient and local inhibition of endometrial STAT-3 activaton results in implantation failure. FEBS Lett 2006; 580 : 2717-22.  Back to cited text no. 53
    
54.
Kano A, Wolfgang MJ, Gao Q, Jacoby J, Chai G, Hansen W, et al. Endothelial cells require STAT3 for protection against endotoxin-induced inflammation. J Exp Med 2003; 198 : 1517-25.  Back to cited text no. 54
    
55.
Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vacsular disease. Biochem Pharmacol 2009; 78 : 539-52.  Back to cited text no. 55
    
56.
Ghosh D, Sengupta J, Hendrickx AG. Effect of a single dose, early luteal phase administration of mifepristone (RU486) on implantation stage endometrium in the rhesus monkey. Hum Reprod 1996; 11 : 2026-35.  Back to cited text no. 56
    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1], [Table 2]



 

Top
 
 
  Search
 
    Similar in PUBMED
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed771    
    Printed15    
    Emailed0    
    PDF Downloaded240    
    Comments [Add]    

Recommend this journal